Sign Up to like & get
recommendations!
1
Published in 2023 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2023.1109866
Abstract: Ropeginterferon alfa-2b is a novel, long-acting mono-pegylated proline-IFN-alpha-2b approved for treatment of polycythemia vera in adults, regardless of thrombotic risk level or treatment history. Clinical trial data indicate the dose and titration of ropeginterferon alfa-2b…
read more here.
Keywords:
ropeginterferon alfa;
dosing strategy;
alternative dosing;
ropeginterferon ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2023 at "Frontiers in Pharmacology"
DOI: 10.3389/fphar.2023.1055329
Abstract: Following infection with Mycobacterium tuberculosis, young children are at high risk of developing severe forms of tuberculosis (TB) disease, including TB meningitis (TBM), which is associated with significant morbidity and mortality. In 2022, the World…
read more here.
Keywords:
meningitis;
dosing strategy;
treatment regimen;
tbm regimen ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2023 at "Pharmaceutics"
DOI: 10.3390/pharmaceutics15020556
Abstract: The rapid onset of action of nifedipine causes a precipitous reduction in blood pressure leading to adverse effects associated with reflex sympathetic nervous system (SNS) activation, including tachycardia and worsening myocardial and cerebrovascular ischemia. As…
read more here.
Keywords:
virtual clinical;
formulation;
clinical trials;
dosing strategy ... See more keywords